SCHEMBL18652074

SCHEMBL18652074

CC(C)(CCOC(C)(C)C)CNC(=O)c1ccc(B(O)O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 5/20 0.44
▸ PRSS1 P07477 1/20 0.39
▸ CTSG P08311 1/20 0.39
▸ CTRB1 P17538 1/20 0.39
▸ CMA1 P23946 1/20 0.39
▸ NAMPT P43490 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ GPR55 Q9Y2T6 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18698021 0.86 TRPV1 (0.46) TRPV1PRSS1CTSGCTRB1CMA1
SCHEMBL22040078 0.81 TRPV1 (0.54) TRPV1PRSS1CTSGCTRB1CMA1
SCHEMBL19233211 0.81 TRPV1 (0.46) TRPV1NAMPTHTTRAB9A
SCHEMBL19478063 0.78 LMNA (0.40) ALDH1A1LMNACYP1A2CYP3A4CYP2D6
SCHEMBL16738817 0.77 TRPV1 (0.53) TRPV1PRSS1CTSGCTRB1CMA1
SCHEMBL2590735 0.72 TRPV1 (0.50) TRPV1NAMPTMLYCD
SCHEMBL25893618 0.72 TRPV1 (0.45) TRPV1ALDH1A1RAB9AMLYCD
SCHEMBL4688446 0.71 DGAT1 (0.47) TRPV1ALDH1A1LMNARAB9A
SCHEMBL1490749 0.71 HPGD (0.62) TRPV1NAMPTALDH1A1MEN1RAB9A
SCHEMBL29950607 0.71 KDM4E (0.55) TRPV1ALDH1A1LMNAMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323628-B1 CARRIER NANOPARTICLES AND RELATED COMPOSITIONS, METHODS AND SYSTEMS CALIFORNIA INST OF TECHN (US) 2022-04-13 — — EP disclosed
US-20210283258-A1 TARGETED NANOPARTICLES CALIFORNIA INSTITUTE OF TECHNOLOGY 2021-09-16 — — US disclosed
EP-3714903-A1 NANOPARTICLES STABILIZED WITH NIITROPHENYLBORONIC ACID COMPOSITIONS California Institute of Technology (US) 2020-09-30 — — EP disclosed
EP-3513812-B1 NANOPARTICLES STABILIZED WITH NITROPHENYLBORONIC ACID COMPOSITIONS CALIFORNIA INST OF TECHN (US) 2020-07-15 — — EP disclosed
US-20190314520-A1 Carrier Nanoparticles And Related Compositions, Methods And Systems CALIFORNIA INSTITUTE OF TECHNOLOGY 2019-10-17 — — US disclosed
US-10342879-B2 Carrier nanoparticles and related compositions, methods and systems CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2019-07-09 — — US disclosed
US-20190000990-A1 Carrier Nanoparticles And Related Compositions, Methods And Systems CALIFORNIA INSTITUTE OF TECHNOLOGY 2019-01-03 — — US disclosed
US-9913911-B2 Carrier nanoparticles and related compositions, methods and systems CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2018-03-13 — — US disclosed
US-20170080099-A1 CARRIER NANOPARTICLES AND RELATED COMPOSITIONS, METHODS AND SYSTEMS CALIFORNIA INSTITUTE OF TECHNOLOGY 2017-03-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10342879-B2 Carrier nanoparticles and related compositions, methods and systems CA13, CA12, CLTA TRPV1 3659/4885PRSS1 2463/4885CTSG 837/4885
US-20190314520-A1 Carrier Nanoparticles And Related Compositions, Methods And Systems CA13, CA12, CLTA TRPV1 3659/4885PRSS1 2463/4885CTSG 837/4885
US-20210283258-A1 TARGETED NANOPARTICLES CLTB, NBAS, NAPA TRPV1 3494/4885PRSS1 1995/4885CTSG 2325/4885
US-20190000990-A1 Carrier Nanoparticles And Related Compositions, Methods And Systems CA13, CA12, CLTA TRPV1 3659/4885PRSS1 2463/4885CTSG 837/4885
US-20170080099-A1 CARRIER NANOPARTICLES AND RELATED COMPOSITIONS, METHODS AND SYSTEMS CA13, CA12, CLTA TRPV1 3659/4885PRSS1 2463/4885CTSG 837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback